Waltham, MA, May 19,
2020 — Trinity Life Sciences,
a leader in global life sciences solutions, is sharing findings from its latest
TGaS Landscape report entitled, “Launch Excellence Advisory Study.” The report
is based on interviews of 30 biopharmaceutical company Chief Commercial
Officers who shared their experience on the type of drug launch preparation
necessary to ensure success.
One of the major take-aways was that pharmaceutical
companies with “too much budget” were less likely to have high performing launches.
Of…
Read Now
Waltham, Mass., May 6,
2020 — Trinity Life Sciences,
a leader in global life sciences commercialization solutions, announced the
availability of its 2019 Trinity Drug
Index, a commercial analysis of 26 unique therapeutic agents approved in
2016. The Index shows several new trends in drug approvals and evaluates actual
commercial performance of novel drugs post-approval.
The Trinity Drug Index outlines key themes and emerging
trends in the industry as more targeted and innovative products emerge. Scoring
is based on a…
Read Now
Waltham, MA, April 28, 2020 — Trinity Life Sciences, a leader in global
life sciences solutions, announced today the availability of a new TGaS
benchmarking assessment that identifies the high-risk functions within pharma
that are least prepared for challenges generated by the COVID-19 pandemic.
Sales rep
training, forecasting, competitive intelligence, patient support services and
KOL relationship management are among the highest risk functions that need to
consider significant evolution to adjust to a current and post-pandemic world.
“The
COVID-19 crisis…
Read Now
Waltham, MA, April 22, 2020 — Trinity Life Sciences, a leader in global
life sciences solutions, announced today the availability of a new brief
regarding the impact of COVID-19 on telehealth.
The brief, based on a survey of 561 healthcare providers
(HCPs) in the U.S., finds that 46 percent of healthcare providers across a wide
range of specialties are using more telemedicine than before COVID-19.
Radiologists, psychiatrists and cardiologists are leading the charge in
providing telemedicine, but many other specialties…
Read Now
Waltham, MA, April 14,
2020 – Trinity Life Sciences, a global leader in life sciences solutions,
today announced it has named Peter Hoenigsberg to its Board of Directors. Mr.
Hoenigsberg’s CEO and private equity experience brings a valuable level of
business knowledge and perspective to the Board.
Mr. Hoenigsberg most recently was a senior advisor for
Providence Equity Partners helping build their information services portfolio.
Prior to joining Providence, he was CEO of Decision Resources Group (DRG), a highly
successful…
Read Now
Waltham, MA, April 9, 2020 — Trinity Life Sciences, a leader in global life sciences solutions, and Toluna, a leading consumer intelligence platform that delivers insights on demand, announced today the availability of a new brief regarding the impact of COVID-19 on healthcare market research.
The co-sponsored brief, based on a survey of approximately 560 healthcare providers in the U.S., finds that physicians in private practices or community settings have an increased availability to participate in research. This increase in…
Read Now
Waltham, MA, March 19,
2020 — Trinity Life Sciences,
a leader in global life sciences solutions, announces the availability of
Trinity EthnoCapture, a digital approach to understanding the patient journey.
The full-service solution uses multiple online tools (including digital
diaries, online bulletin boards, online messaging discussions and archetyping) to
uncover deep insights into patients’ clinical and emotional experiences.
One
of the reasons digital ethnography is becoming more desirable is because
healthcare providers are becoming less easy to recruit in person…
Read Now
Uncategorized
Waltham, MA, March 10,
2020 — Trinity Life Sciences,
a leader in global life sciences solutions, is launching an ongoing advisory
program that will monitor the effects of the novel coronavirus on
biopharmaceutical companies operations. The advisory is based on the feedback
from surveyed pharmaceutical companies in the TGaS network, a division of
Trinity.
Some of the immediate results show that 100 percent of biopharmaceutical
companies participating in the survey say they have travel restrictions in
place. Eleven out of…
Read Now
Waltham, MA, March 10,
2020 — Trinity Life Sciences,
a leader in global life sciences solutions, is launching an ongoing advisory
program that will monitor the effects of the novel coronavirus on
biopharmaceutical companies operations. The advisory is based on the feedback
from surveyed pharmaceutical companies in the TGaS network, a division of
Trinity.
Some of the immediate results show that 100 percent of biopharmaceutical
companies participating in the survey say they have travel restrictions in
place. Eleven out of…
Read Now
Uncategorized
Waltham, MA., March 9,
2020 — Trinity Life Sciences,
a leader in global life sciences solutions, announces the availability of the
first and only end-to-end market access consulting solution for
biopharmaceutical companies. The new offering includes expertise on market
access, pricing and contracting along with the best-in-class organizational
approaches needed to successfully commercialize biopharmaceutical products.
“As public pressure for pricing transparency for therapies
that extend and save lives increases, the need for an integrated, seamless
solution that demonstrates the differentiated…
Read Now
